LALPATHLAB · Dr. Lal Path Labs Ltd. · Financials
Volume · Nov 13
11.86K
Avg daily vol (3M)
17.37K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
27.63B
+12.2%
FY2026
Net Income
5.05B
+3.6%
FY2026
Operating Cash Flow
6.36B
+11.8%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| INR | 30.34B | 27.63B | 24.61B | 22.27B | 20.17B | 20.87B | 15.81B | 13.3B | 12.03B | 10.57B |
| INR | 1.78B | 1.62B | 1.42B | 1.44B | 1.5B | 1.08B | 772M | 728M | 382M | 331M |
| INR | 266M | 228M | 223M | 294M | 375M | 302M | 160M | 153M | 8M | 8M |
| INR | — | 6.69B | 6.25B | 5.06B | 3.44B | 4.75B | 3.94B | 3.11B | 3.01B | 2.61B |
| INR | 1.86B | 1.59B | 1.33B | 1.43B | 1.03B | 1.25B | 979M | 829M | 1B | 895M |
| INR | 5.84B | 5.05B | 4.87B | 3.58B | 2.39B | 3.45B | 2.92B | 2.26B | 1.99B | 1.71B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 8.51B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.